Chanda A. Miller is a trial attorney who serves as defense counsel for companies in high-stakes product liability litigation and complex commercial cases. She is a strategic thinker who helps clients involved in critical proceedings focus on their long-term litigation goals and their business goals.
OVERVIEW
Chanda A. Miller
Partner
OVERVIEW
Chanda A. Miller
Partner
Chanda A. Miller is a trial attorney who serves as defense counsel for companies in high-stakes product liability litigation and complex commercial cases. She is a strategic thinker who helps clients involved in critical proceedings focus on their long-term litigation goals and their business goals.
- OVERVIEW
- EXPERIENCE
- Experience
- INSIGHTS & EVENTS
OVERVIEW
A trusted adviser, Chanda has handled sophisticated multidistrict litigation, coordinated state proceedings, class actions, complex commercial cases, and appeals throughout the country.
Pharmaceutical manufacturers and medical device companies seek Chanda’s representation to defend against allegations of failure to warn, design and manufacturing defects, Medicaid fraud, violations of state consumer protection and deceptive trade practice acts, and breach of warranty and common law fraud. Chanda frequently serves as defense liaison counsel in coordinated proceedings. She also represents companies in class actions, commercial disputes, and appellate litigation.
Chanda has experience in venues across the nation that frequently see a number of significant MDLs and class actions. She is also experienced in assessing and mitigating business risk under the Pennsylvania Business Corporation Law when handling sophisticated commercial litigation.
Chanda is a frequent author on various topics, including federal guidances relevant to pharmaceutical and medical device companies and personal jurisdiction. In addition, Chanda has an active pro bono practice representing minors and adults in civil rights and name change proceedings.
During law school, she completed an internship with the Honorable Glynnis D. Hill in the Philadelphia County Court of Common Pleas and an externship with the Honorable Bruce Kauffman (Ret.) in the U.S. District Court for the Eastern District of Pennsylvania.
Professional and Community Involvement
President-elect, Philadelphia VIP
Member, International Association of Defense Counsel
Member, Defense Research Institute, Drug and Medical Device Committee
Member, Pennsylvania Bar Association
Member, Philadelphia Bar Association
Board member and chair of strategic planning committee, Philadelphia VIP
Board member, Historic St. George’s Preservation Society
Board of trustees member and treasurer, Historic St. George’s United Methodist Church
Secretary, Thomas Skelton Harrison Foundation
Fellow, Leadership Philadelphia Core Class, 2020-2021
Honors
JD Supra Top Author Readers’ Choice Awards, 2022
Education Law Center Pro Bono Award, 2016
The Public Interest Law Center Pro Bono Partner of the Month, 2015
EXPERIENCE
Experience
- Defended pharmaceutical manufacturer as part of national counsel team and as state liaison counsel in multidistrict litigation involving anticoagulant medication
- Represented pharmaceutical manufacturers in Pennsylvania Superior Court in successful defense of trial court’s dismissal of plaintiffs’ case for failure to comply with trial court orders
- Defended pharmaceutical manufacturer in civil actions filed in venues across the county by state attorneys general in litigation involving antipsychotic medication
- Defended medical device manufacturer in various state and federal court actions alleged product liability, breach of warranty, and common law fraud
- Represented diagnostic company in nationwide price-fixing class action, including on interlocutory appeal of district court’s class certification order, where the Third Circuit vacated the order and held for the first time that the Daubert standard for admissibility applies to expert testimony at the class certification stage
- Represented public agency in Pennsylvania Commonwealth Court in successful defense of agency’s decision to approve a regulatory action before the agency and to deny petitions to intervene in that transaction
INSIGHTS & EVENTS
